Product NDC: | 0228-2551 |
Proprietary Name: | Diclofenac Sodium |
Non Proprietary Name: | Diclofenac Sodium |
Active Ingredient(s): | 75 mg/1 & nbsp; Diclofenac Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0228-2551 |
Labeler Name: | Actavis Elizabeth LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074514 |
Marketing Category: | ANDA |
Start Marketing Date: | 19960326 |
Package NDC: | 0228-2551-06 |
Package Description: | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0228-2551-06) |
NDC Code | 0228-2551-06 |
Proprietary Name | Diclofenac Sodium |
Package Description | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0228-2551-06) |
Product NDC | 0228-2551 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Diclofenac Sodium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19960326 |
Marketing Category Name | ANDA |
Labeler Name | Actavis Elizabeth LLC |
Substance Name | DICLOFENAC SODIUM |
Strength Number | 75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |